🇺🇸 FDA
Patent

US 7419991

3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, compositions, and methods for the use thereof

granted A61KA61K31/4245A61K31/4439

Quick answer

US patent 7419991 (3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, compositions, and methods for the use thereof) held by PTC THERAPEUTICS, INC. expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/4245, A61K31/4439, A61K31/454, A61K31/4545